Literature DB >> 10704563

Intralenticular Candida species abscess in a premature infant.

G K Shah1, J Vander, R C Eagle.   

Abstract

PURPOSE: To report the clinical and histopathologic findings of a premature infant with severe retinopathy of prematurity complicated by the development of an intralenticular fungal abscess.
METHODS: Case report and literature review.
RESULTS: A markedly premature infant developed Candida septicemia at 29 weeks postconception. Over the ensuing 10 weeks, cataract and intraocular inflammation developed sequentially in each eye, as did progressive retinopathy of prematurity with tractional retinal detachment. Pars plana vitrectomy and lensectomy revealed intralenticular Candida species abscess.
CONCLUSION: Progressive cataract and intraocular inflammation in a low birth weight infant may be caused by endogenous intraocular infection secondary to systemic candidiasis. Cataract secondary to retinopathy of prematurity is rare.

Entities:  

Mesh:

Year:  2000        PMID: 10704563     DOI: 10.1016/s0002-9394(99)00404-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  [Endogenous Candida lens abscess in a premature infant].

Authors:  Achim Fieß; J Bauer; C Schindel; M Knuf; S Dithmar
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

2.  Trends in Infantile Endogenous Endophthalmitis Hospitalizations in the United States: An Analysis from 2007 through 2014 Using the National Inpatient Sample.

Authors:  Chandana Papudesu; Tahreem Mir; Wei Fang; Jesse Thompson; David M Hinkle
Journal:  Ophthalmol Retina       Date:  2020-05-06

3.  Candida species lens abscesses in infants with a history of neonatal Candida sepsis.

Authors:  Natario L Couser; G Baker Hubbard; Lyndon B Lee; Amy K Hutchinson; Scott R Lambert
Journal:  J AAPOS       Date:  2013-04       Impact factor: 1.220

Review 4.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.